419
Views
27
CrossRef citations to date
0
Altmetric
Review Article

Alginate as an immobilization material for MAb production via encapsulated hybridoma cells

&
Pages 145-159 | Accepted 12 Oct 2009, Published online: 09 Mar 2010

References

  • Aebischer P, Goddard M, Tresco P. 1993. Cell encapsulation for the nervous system. In:Goosen MFA, ed. Fundamentals of Animal Cell Encapsulation and Immobilization (pp. 197–224). Boca Raton, FL: CRC Press.
  • Arús L, Orive G, Hernández R, Rodriguez A, Rojas A, Pedraz JL. 2005. The influence of cellular seeding density in the microencapsulation of hybridoma cells. J Biomater Sci Polym Ed 16: 521–529.
  • Benson JP, Papas KK, Constantinidis I, Sambanis A. 1997. Towards the development of a bioartificial pancreas: effects of poly-L-lysine on alginate beads with BTC3 cells. Cell Transplant 6: 395–402.
  • Blandino A, Macías M, Cantero D. 1999. Formation of calcium alginate gel capsules: influence of sodium alginate and CaCl2 concentration on gelation kinetics. J Biosci Bioeng 88: 686–689.
  • Boninsegna S, Toso RD, Monte RD. 2003. Alginate microspheres loaded with animal cells and coated by a siliceous layer. J Sol-Gel Sci Technol 26: 1151–1157.
  • Braek GS, Grasdalen H, Smidsrod O. 1986. Tailoring of alginates by enzymatic modification in vitro. Int J Biolog Macromol (8)6: 330–336.
  • Breguet V, Gugerli R, von Stockar U, Marison IW. 2007. CHO immobilization in alginate/poly-L: -lysine microcapsules: an understanding of potential and limitations. Cytotechnology 53: 81–93.
  • Chen H, Ouyang W, Martoni C, Prakash S. 2009. Genipin cross-linked polymeric alginate-chitosan microcapsules for oral delivery: in vitro analysis. Int J Polym Sci, Hindawi Publishing Corporation, 2009:1–17.
  • Constantinidis I, Rask I, Long RC Jr, Sambanis A. 1999. Effects of alginate composition on the metabolic, secretory, and growth characteristics of entrapped beta TC3 mouse insulinoma cells. Biomaterials 20: 2019–2027.
  • Czermak P, Pörtner R, Brix A. 2009. Special engineering aspects. In Eibl R, Eibl D, Pörtner R, Catapano G, Czermak P eds. Cell and Tissue Reaction Engineering. Germany: Springer-Verlag.
  • Dean RC Jr, Karkare SB, Ray NG, Runstadler PW Jr, Venkatasubramanian K. 1987. Large-scale culture of hybridoma and mammalian cells in fluidized bed bioreactors. Ann N Y Acad Sci 506: 129–146.
  • Draget KI, Smidsrod O, Braek GS. 2002. Alginates from algae. In De Baets S, Vandamme E, Steinbuchel A, eds. Biopolymers 6; Polysaccharides II: Polysaccharides from Eucaryotes (pp. 215–244). Weinheim, Germany: Whiley-VCH.
  • Dusseault J, Tam SK, Ménard M, Polizu S, Jourdan G, Yahia L, Hallé JP. 2006. Evaluation of alginate purification methods: effect on polyphenol, endotoxin, and protein contamination. J Biomed Mater Res A 76: 243–251.
  • Familletti PC. 1991. Immobilization of cells in alginate beads containing cavities for growth of cells in airlift bioreactors. United States Patent. Patent No: 5,073,491.
  • Flickinger MC, Drew SW. 1999. Microencapsulation. In Encyclopedia of Bioprocess Technology: Fermentation, Biocatalysis, and Bioseparation (pp. 1785–1798). USA: John Wiley & Sons.
  • Freshney RI. 2005. Defined media and supplements-glucose. In: Culture of Animal Cells (pp. 122–123). Hoboken, New Jersey: John Wiley & Sons, Inc.
  • Gombotz WR, Wee SF. 1998. Protein release from alginate matrices. Advanced Drug Deliv Rev 31: 267–285.
  • Goosen MFA, Mahmud ESE, Al-Ghafri AS, Al-Hajri HA, Al-Sinani YS, Bugarski B. 1997. Immobilization of cells using electrostatic droplet generation. In Bickerstaff GF, Totowa NJ, eds. Immobilization of Enzymes and Cells (pp. 167–174). Humana Press.
  • Goosen MFA, O’Shea GM, Sun AM. 1987. Microencapsulation of living tissue and cells. United States Patent. Patent No: 4,673,566.
  • Goosen MFA, O’Shea GM, Gharapetian HM, Chou S, Sun AM. 1984. Optimization of microencapsulation parameter. Semipermiable microcapsules as a bioartificial pancreas. Biotechnol Bioeng 27: 146–150.
  • Griffiths B. 1986. Can cell culture medium costs be reduced? Strategies and possibilities. Trends Biotechnol 4(10): 268–272.
  • Griffiths B. 1990. Perfusion systems for cell cultivation. In Dekker M, eds. Large Scale Mammalian Cell Culture Technology (p. 624). New York and Basel.
  • Griffiths JB. 1987. Serum and growth factors in cell culture media—an introductory review. Dev Biol Stand 66: 155–160.
  • Gugerli R, Cantana E, Heinzen C, von Stockar U, Marison IW. 2002. Quantitative study of the production and properties of alginate/poly-L-lysine microcapsules. J Microencapsul 19: 571–590.
  • Hagedorn J, Kargi F. 1990. Production of monoclonal antibodies by hybridoma cells in a flat sheet membrane bioreactor. Biotechnol Prog 6: 220–224.
  • Heath C, Dilwith R, Belfort G. 1990. Methods for increasing monoclonal antibody production in suspension and entrapped cell cultures: biochemical and flow cytometric analysis as a function of medium serum content. J Biotechnol 15: 71–89.
  • Howitt FO, Prideaux EBR. 1932. The isoelectric point of serum-globulin as determined by kataphoresis. Proc R Soc Lond B 112: 24–27.
  • Jen AC, Wake MC, Mikos AG. 1996. Hydrogels for cell immobilization. Biotechnol Bioeng 50: 357–364.
  • Katsanakis N, Katsivelis A, Kintzios S. 2009. Immobilization of electroporated cells for fabrication of cellular biosensors: Physiological effects of the shape of calcium alginate matrices and foetal calf serum. Sensors 9: 378–385.
  • King A, Strand B, Rokstad AM, Kulseng B, Andersson A, Skjåk-Braek G, Sandler S. 2003. Improvement of the biocompatibility of alginate/poly-L-lysine/alginate microcapsules by the use of epimerized alginate as a coating. J Biomed Mater Res A 64: 533–539.
  • King G, Daugulis A, Faulkner P. 1987. Alginate-polylysine microcapsules of controlled membrane molecular weight cutoff for mammalian cells culture engineering. Biotechnol Prog 3: 231–241.
  • Klöck G, Frank, H, Houben, R. 1994. Production of purified alginates suitable for use in immunoisolated transplantation. Appl Microbiol Biotechnol 40: 638–643.
  • Klokk TI, Melvik JE. 2002. Controlling the size of alginate gel beads by use of a high electrostatic potential. J Microencapsul 19: 415–424.
  • Koch S, Schwinger C, Kressler J, Heinzen Ch, Rainov NG. 2003. Alginate encapsulation of genetically engineered mammalian cells: comparison of production devices, methods and microcapsule characteristics. J Microencapsul 20: 303–316.
  • Kupchik HZ, Langer RS, Haberern C, El Deriny S, O’Brien M. 1983. A new method for the three-dimensional in vitro growth of human cancer cells. Exp Cell Res 147: 454–460.
  • Lee GM, Palsson BO. 1990a. simplified method of making alginate-polylysine microcapsules for hybridoma cell culture using RPMI-1640 medium. Biotechnol Techn 4(5): 341–344.
  • Lee GM, Palsson BO. 1990b. Immobilization can improve the stability of hybridoma antibody productivity in serum-free media. Biotechnol Bioeng 36: 1049–1055.
  • Lee GM, Kim SJ, Palsson BO. 1994. Enhanced specific antibody productivity of calcium alginate-entrapped hybridoma is cell line-specific. Cytotechnology 16: 1–15.
  • Lee GM, Varma A, Palsson BO. 1991a. Production of monoclonal antibody using free-suspended and immobilized hybridoma cells: Effect of serum. Biotechnol Bioeng 38: 821–830.
  • Lee GM, Gray JJ, Palsson BO. 1991b. Effect of trisodium citrate treatment on hybridoma cell viability. Biotechnol Techn 5(4): 295–298.
  • Lee GM, Han BK, Kim JH, Palsson BO. 1992b. Effect of Calcium Chloride Treatment on Hybridoma Cell Viability and Growth. Biotechnol Lett 14(10): 891–896.
  • Lee GM, Huard TK, Palsson BO. 1989. Effect of serum concentration on hybridoma cell growth and monoclonal antibody production at various initial cell densities. Hybridoma 8: 369–375.
  • Lee GM, Kaminski MS, Palsson BO. 1992a. observations consistent with autocrine stimulation of hybridoma cell growth and implications for large-scale antibody production. Biotechnol Lett 14(4): 257–262.
  • Lijakovic IP, Bugarski D, Plavsic M, Bugarski B. 2007. Influence of micro-environmental conditions on hybridoma cell growth inside the alginate-poly-L-lysine microcapsule. Proc Biochem 42: 167–174.
  • Lim F. 1983. Reversible microencapsulation of a core material. United States Patent. Patent No: 4,407,957.
  • Lim F, Moss RD. 1979. Culturing of microencapsulated living cells and tissues. Presented at the Fourth International Symposium on Microencapsulation, Miami, Florida.
  • Lim F, Moss RD. 1981. Microencapsulation of living cells and tissues. J Pharm Sci 70: 351–354.
  • Lim F, Sun AM. 1980. Microencapsulated islets as bioartificial endocrine pancreas. Science 210: 908–910.
  • Maiorella B, Howarth B, Shauger A, Inlow D. 1989. Optimized pH control for antibody production. Presented at ACS National Meeting, Miami, FL.
  • Mantalaris N, Panoskaltsis N, Song K, Macedo H. 2009. Ex vivo expansion of encapsulated human cord blood (HCB) CD34+ cells in a rotating wall bioreactor. ISEH 38th Annual Scientific Meeting/Experimental Hematology, Athens, Greece.
  • Martinsen A, Storrø I, Skjårk-Bræk G. 1992. Alginate as immobilization material: III. Diffusional properties. Biotechnol Bioeng 39: 186–194.
  • Martinsen A, Skjåk-Bræk G, Smidsrød O. 1989. Alginate as immobilization material: I. Correlation between chemical and physical properties of alginate gel beads. Biotechnol Bioeng 33: 79–89.
  • McNeely Pettitt, DJ. 1973. In Whistler RL, BeMiller JN, eds. Industrial Gums (pp. 49–82). New York: Academic Press, Inc.
  • Moo-Young M, Bols NC, Overgaard SE, Scharer JM. 1992. Immobilization of biologically active material in capsules prepared from a water-soluble polymer and chitosan acetate. United States Patent. Patent No: 5,116,747.
  • Murakami H, Masui H, Sato GH, Sueoka N, Chow TP, Kano-Sueoka T. 1982. Growth of hybridoma cells in serum-free medium: ethanolamine is an essential component. Proc Natl Acad Sci USA 79: 1158–1162.
  • Nedovic V, Willaert R. 2005. In Hofman M, Anne J, Eds. Applications of Cell Immobilisation Biotechnology. The Netherlands: Springer.
  • Ng YC, Berry JM, Butler M. 1996. Optimization of physical parameters for cell attachment and growth on macroporous microcarriers. Biotechnol Bioeng 50: 627–635.
  • Nilsson K. 1987. Methods for immobilizing animal cells. Trends Biotechnol 5(3): 73–78.
  • Orive G, Hernández RM, Rodríguez Gascón A, Calafiore R, Chang TM, de Vos P, Hortelano G, Hunkeler D, Lacík I, Pedraz JL. 2004. History, challenges and perspectives of cell microencapsulation. Trends Biotechnol 22: 87–92.
  • Papoutsakis ET. 1991. Fluid-mechanical damage of animal cells in bioreactors. Trends Biotechnol 9: 427–437.
  • Pörtner R, Rössing S, Koop M, Lüdemann I. 1997. Kinetic studies on hybridoma cells immobilized in fixed bed reactors. Biotechnol Bioeng 55: 535–541.
  • Posillico EG. 1986. Microencapsulation technology for large-scale antibody production. Bio/Technol 4: 114–117.
  • Reading AH, Miles BJ. 1990. Immobilization of cells with alginate and agarose. United States Patent. Patent No: 4,927,761.
  • Rees DA. 1981. Polysaccharide shapes and their interactions-some recent advances. Pure Appl Chem 53: 1–14.
  • Rees DA, Welsh EJ. 1977. Secondary and tertiary structure of polysaccharides in solutions and gels. Angew Chem Int Edit Engl (16): 214–224.
  • Reuveny S, Velez D, Miller L, Macmillan JD. 1986. Comparison of cell propagation methods for their effect on monoclonal antibody yield in fermentors. J Immunol Methods 86: 61–69.
  • Roscoe JP, Owsianka AM. 1982. Alginate: a reversible semi-solid medium for investigating cell transformation. Br J Cancer 46: 965–969.
  • Rupp R. 1985. Use of cellular microencapsulation in large scale production of monoclonal antibodies. In Tolbert, WF, Feder JCI, eds. Large Scale Mammalian Cell Culture (pp. 97–123). New York: Academic Press.
  • Sakai S, Hashimoto I, Kawakami K. 2008. Production of cell-enclosing hollow-core agarose microcapsules via jetting in water-immiscible liquid paraffin and formation of embryoid body-like spherical tissues from mouse ES cells enclosed within these microcapsules. Biotechnol Bioeng 99: 235–243.
  • Seifert DB, Phillips JA. 1997. Production of small, monodispersed alginate beads for cell immobilization. Biotechnol Prog 13: 569–576.
  • Serp D, Cantana E, Heinzen C, Von Stockar U, Marison IW. 2000. Characterization of an encapsulation device for the production of monodisperse alginate beads for cell immobilization. Biotechnol Bioeng 70: 41–53.
  • Shirai Y, Hashimoto K, Yamaji H, Tokashiki M. 1987. Continuous production of monoclonal antibody with immobilized hybridoma cells in an expanded bed fermentor. Appl Microbiol Biotechnol 26: 495–499.
  • Shirai Y, Hashimoto K, Yamaji H, Kawahara H. 1988. Oxygen uptake rate of immobilized growing hybridoma cells. Appl Microbiol Biotechnol 29: 113–118.
  • Simpson NE, Stabler CL, Simpson CP, Sambanis A, Constantinidis I. 2004. The role of the CaCl2-guluronic acid interaction on alginate encapsulated betaTC3 cells. Biomaterials 25: 2603–2610.
  • Sinacore MS, Creswick BC, Buehler R. 1989. Entrapment and Growth of Murine Hybridoma Cells in Calcium Alginate Microbeads. Nature Bio/Technol 7: 1275–1279.
  • Smidsrod O. 1974. Molecular basis for some physical properties of alginates in the gel state. Faraday Discuss Chem Soc 57: 263–274.
  • Smidsrød O, Skjåk-Braek G. 1990. Alginate as immobilization matrix for cells. Trends Biotechnol 8: 71–78.
  • Smidsrod O, Haug A. 1972. Dependence upon the gel-sol state of the ion-exchange properties of alginates. Acta Chem Scand 26: 2063–2074.
  • Stabler CL, Sambanis A, Constantinidis I. 2002. Effects of alginate composition on the growth and overall metabolic activity of betaTC3 cells. Ann N Y Acad Sci 961: 130–133.
  • Stabler C, Wilks K, Sambanis A, Constantinidis I. 2001. The effects of alginate composition on encapsulated betaTC3 cells. Biomaterials 22: 1301–1310.
  • Strand BL, Mørch YA, Syvertsen KR, Espevik T, Skjåk-Braek G. 2003. Microcapsules made by enzymatically tailored alginate. J Biomed Mater Res A 64: 540–550.
  • Sun AM, O’Shea GM. 1985. Microencapsulation of living cells: a long-term delivery system. J Control Release 2: 137–178.
  • Sutherland IW. 1991. Alginates. In Byrom D, ed. Biomaterials; Novel Materials from Biological Sources (pp. 309–331). Stockton, New York.
  • Thu B, Bruheim P, Espevik T, Smidsrød O, Soon-Shiong P, Skjåk-Braek G. 1996. Alginate polycation microcapsules. I. Interaction between alginate and polycation. Biomaterials 17: 1031–1040.
  • Uludag H, Sefton MV. 1990. Colorimetric assay for cellular activity in microcapsules. Biomaterials 11: 708–712.
  • Vikhrov AA, Markvicheva EA, Mareeva TY, Khaidukov SV, Nesmeyanov VA, Manakov MN, Goergen J-L, Marc A, Zubov VP. 1998. Preparation of pure monoclonal antibody to interleukin-2 by cultivation of hybridoma cells entrapped in novel composite hydrogel beads. Biotechnol Techn 12(1): 11–14.
  • Walsh G. 2003. Monoclonal Antibodies. In: Biopharmaceuticals, Biochemistry and Biotechnology (pp. 409–435, 2nd ed.). England: John Wiley & Sons.
  • Wohlpart D, Gainer J, Kirwan D. 1991. Oxygen uptake by entrapped hybridoma cells. Biotechnol Bioeng 37: 1050–1053.
  • Zhang W, He X. 2009. Encapsulation of living cells in small alginate microcapsules by electrostatic spraying: a parametric study. J Biomech Eng 131, 7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.